34th Annual CFS Chemotherapy Foundation Satellite Symposium
34th Annual CFS™ Chemotherapy Foundation Satellite Symposium®Thursday, November 10, 2016
8:30 AM - 10:00 AM
CME-Certified Concurrent Symposium - Live Taping: Leveraging New Evidence in the Context of Evolving Early-Stage Treatment Standards in HER2-Positive Breast Cancer
New York Marriott Marquis
New York, NY 10036
Room: Julliard Complex (5th Floor)
Registration is complimentary, but seating is limited. Please register here.
This edition of Medical Crossfire®, filmed in conjunction with the 34th Annual CFS Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®,
is designed to provide a dynamic review of current and evolving paradigms in the treatment of HER2-positive breast cancer, including therapeutic decision making in the adjuvant setting, biomarkers, extended adjuvant therapy, and management of treatment-related toxicities.
Our activity chair, Joyce O'Shaughnessy, MD, and our expert faculty, William J. Gradishar MD, FASCO, FACP; Mark Pegram, MD; and Linda T. Vahdat, MD, MBA, will emphasize the cutting-edge clinical research shaping how clinicians treat HER2-positive breast cancer now and how they will in the not-too-distant future.
The activity will include 2 segments: one on critical evaluation of landmark trials and the need for more effective adjuvant approaches and another on how emerging strategies can improve outcomes for patients with early stage HER2-positive breast cancer. Each segment will start with a brief didactic overview before leading into an extensive panel discussion led by Dr. O’Shaughnessy. This extended discussion format will allow ample time for examining the nuances and challenges faced by clinicians in everyday practice and include a discussion of strategies for applying emerging data to clinical practice to improve outcomes for patients. The activity will conclude with an interactive question-and-answer session, followed by an evidence-based summary of the morning’s discussion.
This educational activity is intended for medical oncologists, pathologists, and fellows who treat patients with cancer. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of cancer are also invited to participate.
Review landmark and recent trial data, along with unmet needs in the area of adjuvant therapy for HER2-positive breast cancer
Discuss the application of biomarkers, molecular assays, and other risk-assessment tools in treatment decision making for HER2-positive breast cancer
Explain current standards and emerging approaches for the management of toxicities associated with extended adjuvant treatment of HER2-positive breast cancer
Apply strategies for individualized treatment planning based upon efficacy and safety data, as well as patient and disease characteristics
Joyce A. O'Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Co-Chair Breast Cancer Research Program
The US Oncology Network
William J. Gradishar, MD, FASCO, FACP
Betsy Bramsen Professor of Breast Oncology & Professor of Medicine
Deputy Director, Clinical Network
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Director, Maggie Daley Center for Women's Cancer Care
Deputy Chief, Davison of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Mark Pegram, MD
Stanford Cancer Institute
Professor of Medicine
Weill Cornell Medicine
Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Aknowledgement of Commercial Support
This activity is supported by an educational grant from Puma Biotechnology.
Photos from the 34th Annual CFS™ Chemotherapy Foundation Satellite Symposium®